Dystrobrevin increases dystrophin's binding to the dystrophin-glycoprotein complex and provides protection during cardiac stress

Current Therapeutic Research - Clinical and Experimental

Volumn 76, Issue , 2014, Pages 106-115

  Strakova, Jana ^a   Dean, Jon D ^a   Sharpe, Katharine M ^a   Meyers, Tatyana A ^a   Odom, Guy L ^b   Townsend, DeWayne ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Alpha dystrobrevin; Duchenne muscular dystrophy; Dystrophin; Tubulin

Indexed keywords

ADRENERGIC RECEPTOR; ALPHA DYSTROBREVIN; DYSTROBREVIN; DYSTROPHIN; GLYCOPROTEIN; ISOPRENALINE; MUSCLE PROTEIN; PROTEIN KINASE B; SARCOGLYCAN; TUBULIN; UNCLASSIFIED DRUG; DYSTROPHIN ASSOCIATED PROTEIN; PROTEIN BINDING;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SIZE; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; HEART; HEART DISEASE; HEART INJURY; HEART MUSCLE CELL; HEART PROTECTION; HEART STRESS; MICROTUBULE; MORTALITY; MOUSE; NONHUMAN; PHARMACOLOGIC STRESS TESTING; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; 129 MOUSE; ANIMAL; C57BL MOUSE; CELL CULTURE; METABOLISM; PHYSIOLOGICAL STRESS; PHYSIOLOGY;

ANIMALS; CELLS, CULTURED; DYSTROPHIN; DYSTROPHIN-ASSOCIATED PROTEINS; MICE, 129 STRAIN; MICE, INBRED C57BL; MICROTUBULES; MUSCULAR DYSTROPHY, DUCHENNE; MYOCYTES, CARDIAC; PROTEIN BINDING; SARCOGLYCANS; STRESS, PHYSIOLOGICAL;

EID: 84907551028     PISSN: 0011393X     EISSN: 18790313     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2014.08.013     Document Type: Article

References (51)

1. Frankel K.A., Rosser R.J. The pathology of the heart in progressive muscular dystrophy: epimyocardial fibrosis. Hum Pathol 1976, 7:375-386.
2. Nigro G., Comi L.I., Politano L., Bain R.J. The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol 1990, 26:271-277.
3. Politano L., Nigro V., Nigro G., Petretta V.R., Passamano L., Papparella S., et al. Development of cardiomyopathy in female carriers of Duchenne and Becker muscular dystrophies. JAMA 1996, 275:1335-1338.
4. Bushby K., Finkel R., Birnkrant D.J., Case L.E., Clemens P.R., Cripe L., et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 2010, 9:77-93.
5. Rafael-Fortney J.A., Chimanji N.S., Schill K.E., Martin C.D., Murray J.D., Ganguly R., et al. Early treatment with lisinopril and spironolactone preserves cardiac and skeletal muscle in Duchenne muscular dystrophy mice. Circulation 2011, 124:582-588.
6. Crosbie R.H., Heighway J., Venzke D.P., Lee J.C., Campbell K.P. Sarcospan, the 25-kDa transmembrane component of the dystrophin-glycoprotein complex. J Biol Chem 1997, 272:31221-31224.
7. Ervasti J.M., Campbell K.P. Membrane organization of the dystrophin-glycoprotein complex. Cell 1991, 66:1121-1131.
8. Ervasti J.M., Campbell K.P. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol 1993, 122:809-823.
9. Sadoulet-Puccio H.M., Khurana T.S., Cohen J.B., Kunkel L.M. Cloning and characterization of the human homologue of a dystrophin related phosphoprotein found at the Torpedo electric organ post-synaptic membrane. Hum Mol Genet 1996, 5:489-496.
10. Butler M.H., Douville K., Murnane A.A., Kramarcy N.R., Cohen J.B., Sealock R., et al. Association of the Mr 58,000 postsynaptic protein of electric tissue with Torpedo dystrophin and the Mr 87,000 postsynaptic protein. J Biol Chem 1992, 267:6213-6218.
11. Sadoulet-Puccio H.M., Rajala M., Kunkel L.M. Dystrobrevin and dystrophin: an interaction through coiled-coil motifs. Proc Natl Acad Sci U S A 1997, 94:12413-12418.
12. Suzuki A., Yoshida M., Hayashi K., Mizuno Y., Hagiwara Y., Ozawa E. Molecular organization at the glycoprotein-complex-binding site of dystrophin. Three dystrophin-associated proteins bind directly to the carboxy-terminal portion of dystrophin. Eur J Biochem 1994, 220:283-292.
13. Yoshida M., Yamamoto H., Noguchi S., Mizuno Y., Hagiwara Y., Ozawa E. Dystrophin-associated protein A0 is a homologue of the Torpedo 87K protein. FEBS Lett 1995, 367:311-314.
14. Metzinger L., Blake D.J., Squier M.V., Anderson L.V., Deconinck A.E., Nawrotzki R., et al. Dystrobrevin deficiency at the sarcolemma of patients with muscular dystrophy. Hum Mol Genet 1997, 6:1185-1191.
15. Blake D.J., Nawrotzki R., Peters M.F., Froehner S.C., Davies K.E. Isoform diversity of dystrobrevin, the murine 87-kDa postsynaptic protein. J Biol Chem 1996, 271:7802-7810.
16. Bohm S.V., Constantinou P., Tan S., Jin H., Roberts R.G. Profound human/mouse differences in alpha-dystrobrevin isoforms: a novel syntrophin-binding site and promoter missing in mouse and rat. BMC Biol 2009, 7:85.
17. Enigk R.E., Maimone M.M. Differential expression and developmental regulation of a novel alpha-dystrobrevin isoform in muscle. Gene 1999, 238:479-488.
18. Ichida F., Tsubata S., Bowles K.R., Haneda N., Uese K., Miyawaki T., et al. Novel gene mutations in patients with left ventricular noncompaction or Barth syndrome. Circulation 2001, 103:1256-1263.
19. Bunnell T.M., Jaeger M.A., Fitzsimons D.P., Prins K.W., Ervasti J.M. Destabilization of the dystrophin-glycoprotein complex without functional deficits in alpha-dystrobrevin null muscle. PLoS One 2008, 3:e2604.
20. Yoshida M., Hama H., Ishikawa-Sakurai M., Imamura M., Mizuno Y., Araishi K., et al. Biochemical evidence for association of dystrobrevin with the sarcoglycan-sarcospan complex as a basis for understanding sarcoglycanopathy. Hum Mol Genet 2000, 9:1033-1040.
21. Crawford G.E., Faulkner J.A., Crosbie R.H., Campbell K.P., Froehner S.C., Chamberlain J.S. Assembly of the dystrophin-associated protein complex does not require the dystrophin COOH-terminal domain. J Cell Biol 2000, 150:1399-1410.
22. Yue Y., Liu M., Duan D. C-terminal-truncated microdystrophin recruits dystrobrevin and syntrophin to the dystrophin-associated glycoprotein complex and reduces muscular dystrophy in symptomatic utrophin/dystrophin double-knockout mice. Mol Ther 2006, 14:79-87.
23. Peters M.F., Adams M.E., Froehner S.C. Differential association of syntrophin pairs with the dystrophin complex. J Cell Biol 1997, 138:81-93.
24. Brenman J.E., Chao D.S., Gee S.H., McGee A.W., Craven S.E., Santillano D.R., et al. Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-syntrophin mediated by PDZ domains. Cell 1996, 84:757-767.
25. Nawrotzki R., Loh N.Y., Ruegg M.A., Davies K.E., Blake D.J. Characterisation of alpha-dystrobrevin in muscle. J Cell Sci 1998, 111:2595-2605.
26. Durbeej M., Cohn R.D., Hrstka R.F., Moore S.A., Allamand V., Davidson B.L., et al. Disruption of the beta-sarcoglycan gene reveals pathogenetic complexity of limb-girdle muscular dystrophy type 2E. Mol Cell 2000, 5:141-151.
27. Grady R.M., Grange R.W., Lau K.S., Maimone M.M., Nichol M.C., Stull J.T., et al. Role for alpha-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies. Nat Cell Biol 1999, 1:215-220.
28. Yasuda S., Townsend D., Michele D.E., Favre E.G., Day S.M., Metzger J.M. Dystrophic heart failure blocked by membrane sealant poloxamer. Nature 2005, 436:1025-1029.
29. Townsend D., Blankinship M.J., Allen J.M., Gregorevic P., Chamberlain J.S., Metzger J.M. Systemic administration of micro-dystrophin restores cardiac geometry and prevents dobutamine-induced cardiac pump failure. Mol Ther 2007, 15:1086-1092.
30. Schneider C.A., Rasband W.S., Eliceiri K.W. NIH image to ImageJ: 25years of image analysis. Nat Methods 2012, 9:671-675.
31. Coutu P., Bennett C.N., Favre E.G., Day S.M., Metzger J.M. Parvalbumin corrects slowed relaxation in adult cardiac myocytes expressing hypertrophic cardiomyopathy-linked alpha-tropomyosin mutations. Circ Res 2004, 94:1235-1241.
32. Liu W., Ralston E. A new directionality tool for assessing microtubule pattern alterations. Cytoskeleton (Hoboken) 2014, 71:230-240.
33. Johnson E.K., Zhang L., Adams M.E., Phillips A., Freitas M.A., Froehner S.C., et al. Proteomic analysis reveals new cardiac-specific dystrophin-associated proteins. PLoS One 2012, 7:e43515.
34. Petrof B.J., Shrager J.B., Stedman H.H., Kelly A.M., Sweeney H.L. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci U S A 1993, 90:3710-3714.
35. Khairallah R.J., Shi G., Sbrana F., Prosser B.L., Borroto C., Mazaitis M.J., et al. Microtubules underlie dysfunction in duchenne muscular dystrophy. Sci Signal 2012, 5:ra56.
36. Percival J.M., Gregorevic P., Odom G.L., Banks G.B., Chamberlain J.S., Froehner S.C. rAAV6-microdystrophin rescues aberrant Golgi complex organization in mdx skeletal muscles. Traffic 2007, 8:1424-1439.
37. Prins K.W., Humston J.L., Mehta A., Tate V., Ralston E., Ervasti J.M. Dystrophin is a microtubule-associated protein. J Cell Biol 2009, 186:363-369.
38. Prosser B.L., Ward C.W., Lederer W.J. X-ROS signaling: rapid mechano-chemo transduction in heart. Science 2011, 333:1440-1445.
39. Townsend D., Yasuda S., McNally E., Metzger J.M. Distinct pathophysiological mechanisms of cardiomyopathy in hearts lacking dystrophin or the sarcoglycan complex. FASEB J 2011, 25:3106-3114.
40. Koo T., Malerba A., Athanasopoulos T., Trollet C., Boldrin L., Ferry A., et al. Delivery of AAV2/9-microdystrophin genes incorporating helix 1 of the coiled-coil motif in the C-terminal domain of dystrophin improves muscle pathology and restores the level of alpha1-syntrophin and alpha-dystrobrevin in skeletal muscles of mdx mice. Hum Gene Ther 2011, 22:1379-1388.
41. Sharpe K.M., Premsukh M.D., Townsend D. Alterations of dystrophin-associated glycoproteins in the heart lacking dystrophin or dystrophin and utrophin. J Muscle Res Cell Motil 2013, 34:395-405.
42. Matsumura K., Ervasti J.M., Ohlendieck K., Kahl S.D., Campbell K.P. Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle. Nature 1992, 360:588-591.
43. Yang B., Ibraghimov-Beskrovnaya O., Moomaw C.R., Slaughter C.A., Campbell K.P. Heterogeneity of the 59-kDa dystrophin-associated protein revealed by cDNA cloning and expression. J Biol Chem 1994, 269:6040-6044.
44. Aquila-Pastir L.A., DiPaola N.R., Matteo R.G., Smedira N.G., McCarthy P.M., Moravec C.S. Quantitation and distribution of beta-tubulin in human cardiac myocytes. J Mol Cell Cardiol 2002, 34:1513-1523.
45. Cerecedo D., Cisneros B., Mondragon R., Gonzalez S., Galvan I.J. Actin filaments and microtubule dual-granule transport in human adhered platelets: the role of alpha-dystrobrevins. Br J Haematol 2010, 149:124-136.
46. Mizuno Y., Thompson T.G., Guyon J.R., Lidov H.G., Brosius M., Imamura M., et al. Desmuslin, an intermediate filament protein that interacts with alpha-dystrobrevin and desmin. Proc Natl Acad Sci U S A 2001, 98:6156-6161.
47. Newey S.E., Howman E.V., Ponting C.P., Benson M.A., Nawrotzki R., Loh N.Y., et al. Syncoilin, a novel member of the intermediate filament superfamily that interacts with alpha-dystrobrevin in skeletal muscle. J Biol Chem 2001, 276:6645-6655.
48. Harper S.Q., Hauser M.A., DelloRusso C., Duan D., Crawford R.W., Phelps S.F., et al. Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy. Nat Med 2002, 8:253-261.
49. England S.B., Nicholson L.V., Johnson M.A., Forrest S.M., Love D.R., Zubrzycka-Gaarn E.E., et al. Very mild muscular dystrophy associated with the deletion of 46% of dystrophin. Nature 1990, 343:180-182.
50. Gregorevic P., Blankinship M.J., Allen J.M., Crawford R.W., Meuse L., Miller D.G., et al. Systemic delivery of genes to striated muscles using adeno-associated viral vectors. Nat Med 2004, 10:828-834.
51. Lai Y., Thomas G.D., Yue Y., Yang H.T., Li D., Long C., et al. Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy. J Clin Invest 2009, 119:624-635.